Naive CD4+ cells from cord blood can generate competent Th effector cells

Transplantation

Volumn 80, Issue 6, 2005, Pages 850-858

  Cantó, Elisabet ^a   Rodríguez Sánchez, José L ^a   Vidal, Sílvia ^a,b  

^a HOSPITAL DE LA SANTA CREU I SANT PAU   (Spain)

^b Hospital Sant Pau S Antoni M Claret 167   (Spain)

Author keywords

CD4+; Cord; Effector; Human; Lymphocytes; Naive

Indexed keywords

CD4 ANTIGEN; CD40 LIGAND; CD45 ANTIGEN; CD69 ANTIGEN; CYTOTOXIC T LYMPHOCYTE ANTIGEN 4; GAMMA INTERFERON; INTERLEUKIN 10; INTERLEUKIN 2; INTERLEUKIN 4; INTERLEUKIN 5; MESSENGER RNA; MONOCLONAL ANTIBODY; OKT 3; PADGEM PROTEIN;

ALLOGENEIC STEM CELL TRANSPLANTATION; ARTICLE; CELL DIFFERENTIATION; CONTROLLED STUDY; EFFECTOR CELL; GENE EXPRESSION REGULATION; GRAFT VERSUS HOST REACTION; HELPER CELL; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMAN; HUMAN CELL; HUMAN EXPERIMENT; IMMUNOREGULATION; IN VITRO STUDY; NORMAL HUMAN; PERIPHERAL CIRCULATION; PRIORITY JOURNAL; RISK ASSESSMENT; UMBILICAL CORD BLOOD;

BIOLOGICAL MARKERS; CD4-POSITIVE T-LYMPHOCYTES; CELL DIFFERENTIATION; CELL PROLIFERATION; CELLS, CULTURED; CYTOKINES; FETAL BLOOD; HUMANS; LYMPHOCYTE ACTIVATION; RECEPTORS, ANTIGEN, T-CELL; RNA, MESSENGER;

EID: 26644451620     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.TP.0000174135.32068.65     Document Type: Article

References (45)

1. Gluckman E, Rocha V, Boyer-Chammard A, et al. Outcome of cord-blood transplantation from related and unrelated donors. Eurocord Transplant Group and the European Blood and Marrow Transplantation Group. N Engl J Med 1997; 337: 373.
2. Rubinstein P, Carrier C, Scaradavou A, et al. Outcomes among 562 recipients of placental-blood transplants from unrelated donors. N Engl J Med 1998; 339: 1565.
3. D'Arena G, Musto P, Cascavilla N, et al. Inability of activated cord blood T lymphocytes to perform Th1-like and Th2-like responses: implications for transplantation. J Hematother Stem Cell Res 1999; 8: 381.
4. Matthews NC, Wadhwa M, Bird C, et al. Sustained expression of CD 154 (CD40L) and proinflammatory cytokine production by alloantigen-stimulated umbilical cord blood T cells. J Immunol 2000; 164: 6206.
5. Blazar BR, Korngold R, Vallera DA. Recent advances in graft-versus-host disease (GVHD) prevention. Immunol Rev 1997; 157: 79.
6. Krampera M, Tavecchia L, Benedetti F, et al. Intracellular cytokine profile of cord blood T-, and NK- cells and monocytes. Haematologica 2000; 85: 675.
7. Schibler KR, Liechty KW, White WL, et al. Defective production of interleukin-6 by monocytes: a possible mechanism underlying several host defense deficiencies of neonates. Pediatr Res 1992; 31: 18.
8. Trivedi HN, HayGlass KT, Gangur V, et al. Analysis of neonatal T cell and antigen presenting cell functions. Hum Immunol 1997; 57: 69.
9. Varis I, Deneys V, Mazzon A, et al. Expression of HLA-DR, CAM and co-stimulatory molecules on cord blood monocytes. Eur J Haematol 2001; 66: 107.
10. Malhotra I, Ouma J, Wamachi A, et al. In utero exposure to helminth and mycobacterial antigens generates cytokine responses similar to that observed in adults. J Clin Invest 1997; 99: 1759.
11. Chalmers IM, Janossy G, Contreras M, Navarrete C. Intracellular cytokine profile of cord and adult blood lymphocytes. Blood 1998; 92: 11.
12. Sasama J, Vyas B, Vukmanovic-Stejic M, Kemeny DM. Effect of IL-4, IFN-gamma and IL-12 on cytokine production from human CD45RA and CD45RO CD4 T cell precursors. Int Arch Allergy Immunol 1998; 117: 255.
13. Hassan J, Reen DJ. Human recent thymic emigrants-identification, expansion, and survival characteristics. J Immunol 2001; 167: 1970.
14. Canto E, Rodriguez-Sanchez JL, Vidal S. Distinctive response of naive lymphocytes from cord blood to primary activation via TCR. J Leukoc Biol 2003; 74: 998.
15. Constant S, Pfeiffer C, Woodard A, et al. Extent of T cell receptor ligation can determine the functional differentiation of naive CD4+ T cells. J Exp Med 1995; 182: 1591.
16. Delespesse G, Yang LP, Ohshima Y, et al. Maturation of human neonatal CD4+ and CD8+ T lymphocytes into Th1/Th2 effectors. Vaccine 1998; 16: 1415.
17. Cousins DJ, Lee TH, Staynov DZ. Cytokine coexpression during human Th1/Th2 cell differentiation: direct evidence for coordinated expression of Th2 cytokines. J Immunol 2002; 169: 2498.
18. Sundrud MS, Grill SM, Ni D, et al. Genetic reprogramming of primary human T cells reveals functional plasticity in Th cell differentiation. J Immunol 2003; 171: 3542.
19. Linsley PS, Bradshaw J, Urnes M, et al. CD28 engagement by B7/BB-1 induces transient down-regulation of CD28 synthesis and prolonged unresponsiveness to CD28 signaling. J Immunol 1993; 150: 3161.
20. Bullens DM, Kasran A, Peng X, et al. Effects of anti-IL-4 receptor monoclonal antibody on in vitro T cell cytokine levels: IL-4 production by T cells from non-atopic donors. Clin Exp Immunol 1998; 113: 320.
21. Agata Y, Kawasaki A, Nishimura H, et al. Expression of the PD-1 antigen on the surface of stimulated mouse T and B lymphocytes. Int Immunol 1996; 8: 765.
22. Krummel MF, Allison JP. CD28 and CTLA-4 have opposing effects on the response of T cells to stimulation. J Exp Med 1995; 182: 459.
23. Hamann D, Baars PA, Hooibrink B, van Lier RW. Heterogeneity of the human CD4+ T-cell population: two distinct CD4+ T-cell subsets characterized by coexpression of CD45RA and CD45RO isoforms. Blood 1996; 88: 3513.
24. Arlettaz L, Barbey C, Dumont-Girard F, et al. CD45 isoform phenotypes of human T cells: CD4(+)CD45RA(-)RO(+) memory T cells re-acquire CD45RA without losing CD45RO. Eur J Immunol 1999; 29: 3987.
25. Flynn S, Toellner KM, Raykundalia C, et al. CD4 T cell cytokine differentiation: the B cell activation molecule, OX40 ligand, instructs CD4 T cells to express interleukin 4 and upregulates expression of the chemokine receptor, Blr-1. J Exp Med 1998; 188: 297.
26. Cella M, Scheidegger D, Palmer-Lehmann K, et al. Ligation of CD40 on dendritic cells triggers production of high levels of interleukin-12 and enhances T cell stimulatory capacity: T-T help via APC activation. J Exp Med 1996; 184: 747.
27. Koch F, Stanzl U, Jennewein P, et al. High level IL-12 production by murine dendritic cells: upregulation via MHC class II and CD40 molecules and downregulationby IL-4 and IL-10. J Exp Med 1996; 184: 741.
28. Scott ME, Kubin M, Kohl S. High level interleukin-12 production, but diminished interferon-gamma production, by cord blood mononuclear cells. Pediatr Res 1997; 41: 547.
29. Barth H, Berg PA, Klein R. Methods for the in vitro determination of an individual disposition towards TH1- or TH2-reactivity by the application of appropriate stimulatory antigens. Clin Exp Immunol 2003; 134: 78.
30. Rogers PR, Huston G, Swain SL. High antigen density and IL-2 are required for generation of CD4 effectors secreting Th1 rather than Th0 cytokines. J Immunol 1998; 161: 3844.
31. Goriely S, Vincart B, Stordeur P, et al. Deficient IL-12(p35) gene expression by dendritic cells derived from neonatal monocytes. J Immunol 2001; 166: 2141.
32. Marodi L, Goda K, Palicz A, Szabo G. Cytokine receptor signalling in neonatal macrophages: defective STAT-1 phosphorylation in response to stimulation with IFN-gamma. Clin Exp Immunol 2001; 126: 456.
33. Buelens C, Bartholome EJ, Amraoui Z, et al. Interleukin-3 and Interferon beta cooperate to induce differentiation of monocytes into dendritic cells with potent helper T-cell stimulatory properties. Blood 2002; 99: 993.
34. Klein-Hessling S, Jha MK, Santner-Nanan B, et al. Protein kinase A regulates GATA-3-dependent activation of IL-5 gene expression in Th2 cells. J Immunol 2003; 170: 2956.
35. Wang X, Mosmann T. In vivo priming of CD4 T cells that produce interleukin (IL)-2 but not IL-4 or Interferon (IFN)-gamma, and can subsequently differentiate into IL-4- or IFN-gamma-secreting cells. J Exp Med 2001; 194: 1069.
36. Lanzavecchia A, Sallusto F. Dynamics of T lymphocyte responses: intermediates, effectors, and memory cells. Science 2000; 290: 92.
37. Noble A, Thomas MJ, Kemeny DM. Early Th1/Th2 cell polarization in the absence of IL-4 and IL-12: T cell receptor signaling regulates the response to cytokines in CD4 and CDS T cells. Eur J Immunol 2001; 31: 2227.
38. Openshaw P, Murphy EE, Hosken NA, et al. Heterogeneity of intracellular cytokine synthesis at the single-cell level in polarized T helper 1 and T helper 2 populations. J Exp Med 1995; 182: 1357.
39. Han P, Hodge G. Intracellular cytokine production and cytokine receptor interaction of cord mononuclear cells: relevance to cord blood transplantation. Br J Haematol 1999; 107: 450.
40. Li L, Lee HH, Bell JJ, et al. IL-4 utilizes an alternative receptor to drive apoptosis of Th1 cells and skews neonatal immunity toward Th2. Immunity 2004; 20: 429.
41. Nakamura T, Lee RK, Nam SY, et al. Roles of IL-4 and IFN-gamma in stabilizing the T helper cell type 1 and 2 phenotype. J Immunol 1997; 158: 2648.
42. Nishikomori R, Ehrhardt RO, Strober W. T helper type 2 cell differentiation occurs in the presence of interleukin 12 receptor beta2 chain expression and signaling. J Exp Med 2000; 191: 847.
43. Witsch EJ, Peiser M, Hutloff A, et al. ICOS and CD28 reversely regulate IL-IO on re-activation of human effector T cells with mature dendritic cells. Eur J Immunol 2002; 32: 2680.
44. Taga K, Tosato G. IL-10 inhibits human T cell proliferation and IL-2 production. J Immunol 1992; 148: 1143.
45. de Waal Malefyt R, Haanen J, Spits H, et al. Interleukin 10 (IL-10) and viral IL-10 strongly reduce antigen-specific human T cell proliferation by diminishing the antigen-presenting capacity of monocytes via downregulation of class II major histocompatibility complex expression J Exp Med 1991; 174: 915.